CEVI.ST · PEAD ↑ 100

CellaVision reported Q3 2026 EPS of 1.68 on 2026-10-28, beating the 1.43 consensus by 0.25 (+17.5%).

Print-day reaction was +2.3% versus the prior close, a measured but positive initial read on the beat. The overnight gap to the T+1 open was a substantial +6.4%, signalling strong after-hours conviction with no fade. Over the following two trading days the stock drifted an additional +1.9%, sustaining and extending the move rather than giving it back. Cumulative abnormal return of +14.3% versus SPY.US — which itself fell 2.3% over the same window — firmly places this in PEAD long territory; per the documented pattern, the read is held through 2027-01-25.